» Articles » PMID: 3160727

Effects of Plasmin on Von Willebrand Factor Multimers. Degradation in Vitro and Stimulation of Release in Vivo

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1985 Jul 1
PMID 3160727
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

von Willebrand factor (vWF), a multimeric protein that mediates platelet adhesion, circulates in association with the procoagulant Factor VIII (FVIII). In previous reports, plasmin was shown in vitro to inactivate FVIII and cleave the vWF subunit extensively, but to cause only a modest decrease in vWF platelet-agglutinating activity. In the present study, the digestion of vWF multimers by plasmin was analyzed by sodium dodecyl sulfate-agarose gel electrophoresis and radioimmunoblotting. In vitro, plasmin degraded the large vWF multimers to smaller forms that could be distinguished from the small multimers present before digestion only by a slightly increased electrophoretic mobility. These plasmin-cleaved "multimers" were composed of disulfide-linked fragments with no intact vWF subunits. Thus, many plasmin cleavages occur within disulfide loops. The slight increase in mobility of plasmin-digested vWF is in part explained by the early cleavage from the multimers of a 34,000-mol wt peptide, which was purified and partially sequenced. The amino-terminal sequence (33 residues) agrees with the previously reported sequence (15 residues) for the amino terminus of the intact vWF subunit. Analysis of plasmin-digested vWF allowed deduction of a model for the native vWF structure, including the approximate location of the interprotomer disulfide bond(s). To determine whether plasmin would digest vWF in vivo, plasmas from 12 patients and 2 normal volunteers who received intravenous streptokinase (SK) were analyzed. Rather than vWF digestion, a two- to threefold rise in vWF antigen and platelet-agglutinating activity occurred within 2 h after a single SK dose, and the increase was greatest among the largest multimers. In contrast, FVIII clotting activity dropped to 10-20% of pre-SK levels. Thus, although plasmin destroys FVIII, a pharmacologically induced fibrinolytic state is associated with significant release of vWF from endothelial cells, platelets, or some other storage pool.

Citing Articles

Effects of Plasmin on von Willebrand Factor and Platelets: A Narrative Review.

van der Vorm L, Remijn J, de Laat B, Huskens D TH Open. 2019; 2(2):e218-e228.

PMID: 31249945 PMC: 6524877. DOI: 10.1055/s-0038-1660505.


Elevated Factor VIII and von Willebrand Factor Levels Predict Unfavorable Outcome in Stroke Patients Treated with Intravenous Thrombolysis.

Toth N, Szekely E, Czuriga-Kovacs K, Sarkady F, Nagy O, Lanczi L Front Neurol. 2018; 8:721.

PMID: 29410644 PMC: 5787073. DOI: 10.3389/fneur.2017.00721.


Role of fluid shear stress in regulating VWF structure, function and related blood disorders.

Gogia S, Neelamegham S Biorheology. 2015; 52(5-6):319-35.

PMID: 26600266 PMC: 4927820. DOI: 10.3233/BIR-15061.


Pathological von Willebrand factor fibers resist tissue plasminogen activator and ADAMTS13 while promoting the contact pathway and shear-induced platelet activation.

Herbig B, Diamond S J Thromb Haemost. 2015; 13(9):1699-708.

PMID: 26178390 PMC: 4560981. DOI: 10.1111/jth.13044.


The plasmin-antiplasmin system: structural and functional aspects.

Schaller J, Gerber S Cell Mol Life Sci. 2010; 68(5):785-801.

PMID: 21136135 PMC: 11115092. DOI: 10.1007/s00018-010-0566-5.


References
1.
Deutsch D, MERTZ E . Plasminogen: purification from human plasma by affinity chromatography. Science. 1970; 170(3962):1095-6. DOI: 10.1126/science.170.3962.1095. View

2.
McNicol G, Gale S, Douglas A . In-vitro and in-vivo studies of a preparation of urokinase. Br Med J. 1963; 1(5335):909-15. PMC: 2122826. DOI: 10.1136/bmj.1.5335.909. View

3.
Laemmli U, Favre M . Maturation of the head of bacteriophage T4. I. DNA packaging events. J Mol Biol. 1973; 80(4):575-99. DOI: 10.1016/0022-2836(73)90198-8. View

4.
Mannucci P, Aberg M, Nilsson I, Robertson B . Mechanism of plasminogen activator and factor VIII increase after vasoactive drugs. Br J Haematol. 1975; 30(1):81-93. DOI: 10.1111/j.1365-2141.1975.tb00521.x. View

5.
SWITZER M, McKee P . Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure. J Clin Invest. 1976; 57(4):925-37. PMC: 436736. DOI: 10.1172/JCI108369. View